针灸治疗急性非特异性腰背痛的成本效果分析:随机对照试验二次分析
该研究基于挪威全科医疗多中心随机对照试验的二次分析,纳入171例急性非特异性腰背痛(≤14天)患者,比较常规护理联合单次针刺与单纯常规护理的成本效果。结果发现第28天无质量调整生命年(QALY)增益,第365天增量QALY为0.035且具统计学意义,医疗成本和社会成本差异无统计学意义,四项计算中三项显示负增量成本效果比(ICER)和正净货币收益(NMB)。结论提示从1年视角看针刺可能具成本效果,但需更多研究。
要点
- 单次针刺联合常规护理在急性非特异性腰背痛中第365天增量QALY为0.035。
- 医疗成本和社会成本差异无统计学意义,四项计算中三项显示成本节省。
- 医疗视角第365天ICER为-568美元/QALY,NMB为1265美元。
核心结论
- 从1年视角看,单次针刺联合常规护理对急性非特异性腰背痛可能具成本效果。
研究设计与样本
- 多中心随机对照试验的二次成本效果分析,纳入挪威全科医疗中171例急性非特异性腰背痛(≤14天)患者。
主要发现
- 第28天无QALY增益;第365天增量QALY为0.035,具统计学意义。
- 医疗成本和社会成本差异无统计学意义。
- 四项计算中三项显示负ICER(成本节省)和正NMB。
关键数值与推荐
- 成本效果阈值采用挪威275,000挪威克朗(35,628美元)/QALY。
- 医疗视角第365天ICER为-568美元/QALY,NMB为1265美元,针刺具成本效果的概率为95.9%。
临床怎么用
- 临床可考虑在急性非特异性腰背痛常规护理基础上联合单次针刺,以期1年内可能节省成本并改善健康产出。
局限性
- 本研究为二次分析,缺失数据采用多重链式插补,且需更多研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the cost-effectiveness of a single treatment session of acupuncture, when applied in addition to usual care for acute low back pain (ALBP). METHODS: Secondary analysis of a multicentre randomised controlled trial in Norwegian general practice. In total, 171 participants with ALBP ⩽14 days were randomised to a control group (CG) receiving usual care or to an acupuncture group (AG) receiving one additional session of Western medical acupuncture alongside usual care. Primary outcome measures for this cost-effectiveness analysis were quality-adjusted life years (QALYs), health care costs and societal costs at days 28 and 365, the incremental cost-effectiveness ratio (ICER) and net monetary benefit (NMB). The NMB was calculated on the basis of the Norwegian cost-effectiveness threshold of NOK 275,000 (USD 35,628) per QALY gained. Missing data were replaced by multiple chained imputation. RESULTS: Eighty-six participants in the CG and 81 in the AG were included in the analysis. We found no QALY gain at day 28. At day 365, the incremental QALY of 0.035 was statistically significant. The differences in health care costs and societal costs were not statistically significant. Three out of four calculations led to negative ICERs (cost saving) and positive NMBs. For the health care perspective at day 365, the ICER was USD -568 per QALY and the NMB was USD 1265, with 95.9% probability of acupuncture being cost-effective. CONCLUSION: To our knowledge, this is the first cost-effectiveness analysis of acupuncture for ALBP. The findings indicate that acupuncture may be cost-effective from a 1-year perspective, but more studies are needed. TRIAL REGISTRATION NUMBER: NCT01439412 (ClinicalTrials.gov).
引用
- Skonnord T, Fetveit A, Skjeie H, et al. Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial. Acupunct Med. 2021. PMID: 34847780. doi:10.1177/09645284211055747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。